# CancerTypeNet: Tumor Type Classification from Mutational Signatures

[![Python](https://img.shields.io/badge/Python-3.8%2B-blue)](https://www.python.org/)
[![PyTorch](https://img.shields.io/badge/PyTorch-1.9%2B-red)](https://pytorch.org/)
[![License](https://img.shields.io/badge/License-MIT-green.svg)](LICENSE)

A comprehensive machine learning pipeline for predicting cancer types from mutational signatures using multiple classification models.

## üìã Project Overview

This project implements and compares various machine learning approaches to classify tumor types based on Single Base Substitution (SBS) mutational signatures from the **PCAWG dataset**. We achieve up to **79.5% accuracy** across 22 cancer classes using ensemble methods combining catalog and activity data.

### Key Features

- **Multi-model comparison**: KNN, SVM, Random Forest, Gradient Boosting, DNN, CNN
- **Multi-modal learning**: Combining mutational catalogs (96 channels) and signature activities (65 SBS signatures)
- **Comprehensive evaluation**: Confusion matrices, precision-recall analysis, feature importance
- **Explainable AI**: SHAP values and attention visualization for model interpretability

## üéØ Results Summary

| Model | Dataset | Best Accuracy |
|-------|---------|---------------|
| **DNN** | WGS PCAWG (catalog + activity) | **79.46%** |
| CNN | WGS PCAWG (catalog + activity) | 78.06% |
| KNN | WGS PCAWG (catalog) | 77.84% |
| Gradient Boosting | WGS PCAWG (combined) | 70% |
| Random Forest | WGS PCAWG (catalog) | 68% |
| SVM | WGS PCAWG (catalog) | 41% |

*Note: Results are based on 80-20 train-test split with stratification*

### Performance Visualization

![Model Comparison](results/figures/model_comparison.png)
*Figure 1: Comparison of model accuracies across different datasets (from Summary of Methods slide)*

![Confusion Matrix - DNN](results/figures/confusion_matrix_dnn.png)
*Figure 2: Confusion matrix for Deep Neural Network on combined WGS PCAWG dataset (22 cancer types, 79.46% accuracy)*

![Feature Importance](results/figures/feature_importance_gb.png)
*Figure 3: Feature importance analysis showing C>T mutation channel as most predictive*

## üìä Dataset

### Data Source
Data from [Alexandrov et al. (2020) Nature](https://www.nature.com/articles/s41586-020-1943-3) - "The repertoire of mutational signatures in human cancer"

**Note**: The original datasets are not included in this repository due to size constraints. The data structure is described below for reproduction purposes.

### Data Structure

```
project_data/
‚îú‚îÄ‚îÄ catalogs/
‚îÇ   ‚îú‚îÄ‚îÄ WGS/
‚îÇ   ‚îÇ   ‚îú‚îÄ‚îÄ WGS_PCAWG.96.csv          # 96 channels √ó 2780 samples
‚îÇ   ‚îÇ   ‚îî‚îÄ‚îÄ WGS_Other.96.csv
‚îÇ   ‚îî‚îÄ‚îÄ WES/
‚îÇ       ‚îú‚îÄ‚îÄ WES_TCGA.96.csv           # 96 channels √ó N samples
‚îÇ       ‚îî‚îÄ‚îÄ WES_Other.96.csv
‚îî‚îÄ‚îÄ activities/
    ‚îú‚îÄ‚îÄ WGS/
    ‚îÇ   ‚îú‚îÄ‚îÄ WGS_PCAWG.activities.csv  # 65 SBS signatures √ó 2780 samples
    ‚îÇ   ‚îî‚îÄ‚îÄ WGS_Other.activities.csv
    ‚îî‚îÄ‚îÄ WES/
        ‚îú‚îÄ‚îÄ WES_TCGA.activities.csv   # 65 SBS signatures √ó N samples
        ‚îî‚îÄ‚îÄ WES_Other.activities.csv
```

#### Catalog File Format (e.g., WGS_PCAWG.96.csv)
```
Mutation type | Trinucleotide | Cancer-Type1::Sample1 | Cancer-Type1::Sample2 | ...
C>A          | ACA           | 245                   | 187                   | ...
C>A          | ACC           | 312                   | 298                   | ...
...
```
- Rows: 96 mutation channels (6 base mutations √ó 16 trinucleotide contexts)
- Columns: Sample IDs in format "CancerType::SampleID"
- Values: Mutation counts

#### Activity File Format (e.g., WGS_PCAWG.activities.csv)
```
Cancer Types | Sample Names | Accuracy | SBS1  | SBS2  | ... | SBS94
Biliary-AdenoCA | SP117655  | 0.95     | 2456  | 123   | ... | 0
...
```
- Rows: Individual samples
- Columns: Cancer type, sample name, reconstruction accuracy, 65 SBS signature activities

### Data Availability

The original PCAWG data can be accessed through:
1. **ICGC Data Portal**: [https://dcc.icgc.org/pcawg](https://dcc.icgc.org/pcawg)
2. **Synapse**: Requires registration and data access approval
3. **Supplementary materials** from [Alexandrov et al. 2020](https://www.nature.com/articles/s41586-020-1943-3)

For TCGA data:
- **GDC Data Portal**: [https://portal.gdc.cancer.gov/](https://portal.gdc.cancer.gov/)

### Cancer Types Coverage

- **WGS PCAWG**: 37 cancer types (2,780 samples)
- **WES TCGA**: Multiple cancer types with varying sample sizes
- After filtering (‚â•5 samples): 22 major cancer classes

## üî¨ Methodology

### 1. Data Preprocessing
- **Normalization**: StandardScaler for deep learning models, MedianMAD for KNN
- **Class balancing**: Removed cancer types with <5 samples
- **Feature engineering**: Combined 96 mutation channels with 65 signature activities (161 features)

### 2. Model Architectures

#### Deep Neural Network (Best Performance)
```
Input (161) ‚Üí Dense(128, ReLU, L2, Dropout=0.5) 
           ‚Üí Dense(64, ReLU, L2, Dropout=0.5) 
           ‚Üí Dense(22, Softmax)
```
- Optimizer: Adam (lr=0.001)
- Loss: Sparse Categorical Crossentropy
- Training: 2000 epochs, batch_size=32

#### Convolutional Neural Network
```
Conv1D(1‚Üí14‚Üí18‚Üí1) + Dropout 
‚Üí Flatten 
‚Üí Dense(160‚Üí300‚Üí300‚Üí220‚Üí37)
```
- Regularization: Dropout (0.05-0.07)
- Optimizer: Adam (lr=0.00006)

### 3. Evaluation Metrics
- **Accuracy**: Overall classification accuracy
- **Confusion Matrix**: Per-class performance
- **F1-Score & Recall**: Handling class imbalance
- **Average Precision**: Better metric for imbalanced datasets

## üìà Key Findings

1. **Multi-modal fusion improves accuracy**
   - Catalog only: 77.8%
   - Activity only: 71.7%
   - Combined: **79.5%**

2. **C>T mutations are most informative**
   - Contribute maximally to cancer type prediction
   - ATA trinucleotide context is most important

3. **Deep learning outperforms traditional ML**
   - DNN and CNN achieve 5-10% higher accuracy than ensemble methods

4. **Class imbalance significantly affects performance**
   - Larger cancer types (Liver-HCC, Kidney-RCC) achieve >80% accuracy
   - Rare cancer types show 0% accuracy without proper handling

## üë• Team Members

This project was completed as a collaborative team effort with equal contributions from all members:

- **Team Member 1**
- **Xiaoyu Yuan** - [xiaoyuyuan19@gmail.com](mailto:xiaoyuyuan19@gmail.com)
- **Team Member 3**
- **Team Member 4**

*All team members contributed equally to data analysis, model implementation, and manuscript preparation.*

## üéì Course Information

**Course**: Machine Learning in Molecular Biosciences (LSI31003)  
**Institution**: University of Helsinki  
**Date**: March 2024  
**Type**: Group Course Project

## üîó Related Resources

- [COSMIC Mutational Signatures](https://cancer.sanger.ac.uk/cosmic/signatures)
- [PCAWG Project](https://dcc.icgc.org/pcawg)
- [Original Paper](https://www.nature.com/articles/s41586-020-1943-3)
- [GDC Data Portal](https://portal.gdc.cancer.gov/)

## üìß Contact

**Xiaoyu Yuan**  
Email: xiaoyuyuan19@gmail.com  
Portfolio: [xiaoyuyuan19.github.io/portfolio](https://xiaoyuyuan19.github.io/portfolio/)  
LinkedIn: [linkedin.com/in/xiaoyuyuan19](http://www.linkedin.com/in/xiaoyuyuan19)

## üìÑ License

This project is licensed under the MIT License - see the [LICENSE](LICENSE) file for details.

## üôè Acknowledgments

- Course instructors and teaching assistants at University of Helsinki
- PCAWG Consortium for providing the mutational signature data
- All team members for their equal contributions and collaboration

---

**Note**: This is a course project for educational purposes. The data and methods are based on published research.
